Pasithea Therapeutics Corp. (KTTA)
0.6998
-0.02
(-2.94%)
USD |
NASDAQ |
May 22, 16:00
0.70
0.00 (0.00%)
After-Hours: 20:00
Pasithea Therapeutics EPS Diluted (Quarterly) : -0.1179 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Arcus Biosciences, Inc. | -1.021 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.870M |
| Total Expenses (Quarterly) | 2.870M |
| Enterprise Value | -27.12M |
| Earnings Yield | -296.4% |
| Normalized Earnings Yield | -299.56 |